
Avallano is a clinical research platform that leverages generative artificial intelligence to transform and accelerate clinical trials. The company provides AI-driven tools for protocol analysis, patient engagement, and clinical trial execution, enabling sponsors, CROs, and sites to scale trials efficiently. Avallano's platform simplifies data collection, automates workflows, and enhances patient matching and retention through a user-friendly mobile app. It integrates disparate health records to create comprehensive participant registries and delivers actionable insights on patient demographics and behaviors, reducing operational costs and improving trial outcomes.

Avallano is a clinical research platform that leverages generative artificial intelligence to transform and accelerate clinical trials. The company provides AI-driven tools for protocol analysis, patient engagement, and clinical trial execution, enabling sponsors, CROs, and sites to scale trials efficiently. Avallano's platform simplifies data collection, automates workflows, and enhances patient matching and retention through a user-friendly mobile app. It integrates disparate health records to create comprehensive participant registries and delivers actionable insights on patient demographics and behaviors, reducing operational costs and improving trial outcomes.
Founded: February 14, 2019
Headquarters: Greenville, South Carolina, United States
Product: Mobile marketing and commerce software for collecting self-reported consumer data
Founders: Dean Rogers; Paul Della Maggiora
Funding: Grant from South Carolina Research Authority (Feb 4, 2020)
Consumer data collection and mobile marketing
2019
Mobile marketing / Commerce software
Grant announced Feb 4, 2020
“Received a grant from the South Carolina Research Authority”